Clinical Trial Update: cfMSC Stem Cell Therapy Targeting COPD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of cfMSC stem cell therapy for chronic obstructive pulmonary disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• cfMSC Stem Cell Therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1, Phase 2 | Status: RECRUITING